Cargando…
Delirium in COVID-19: can we make the unknowns knowns?
Autores principales: | Wilcox, M. Elizabeth, Shankar-Hari, Manu, McAuley, Daniel F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244458/ https://www.ncbi.nlm.nih.gov/pubmed/34191039 http://dx.doi.org/10.1007/s00134-021-06467-2 |
Ejemplares similares
-
Paediatric intensive care challenges caused by indirect effects of the COVID-19 pandemic
por: Kanthimathinathan, Hari Krishnan, et al.
Publicado: (2021) -
Role of immunosuppression in an antibiotic stewardship intervention and its association with clinical outcomes and antibiotic use: protocol for an observational study (RISC-sepsis)
por: Scott, Jonathan, et al.
Publicado: (2022) -
Accuracy of LightCycler® SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review protocol
por: Dark, Paul, et al.
Publicado: (2012) -
Mobilisation in the EveNing to TreAt deLirium (MENTAL): protocol for a mixed-methods feasibility randomised controlled trial
por: McWilliams, David, et al.
Publicado: (2023) -
What’s new in ECMO for COVID-19?
por: MacLaren, Graeme, et al.
Publicado: (2020)